Freudenberg Medical has strengthened its leadership team with the appointment of Michael McGee as the new Chief Executive Officer (CEO).

Michael McGee, former COO, assumed the role of Chief Executive Officer, succeeding Dr. Mark Ostwald, who transitioned to another leadership role within the Freudenberg Group.

Michael McGee joined Freudenberg Medical as COO in 2022, bringing more than 30 years of experience in the medical device industry. His appointment to CEO reflects Freudenberg’s commitment to continuity and alignment with the company’s values and long-term strategy.

Under Michael McGee’s leadership, Freudenberg Medical continues to prioritize customer-centricity by investing in advanced technologies, people and processes.

“Since joining Freudenberg Medical, I have been deeply inspired by our company values and our talented global team with proven expertise in materials and technologies. Together, we will build on this strong foundation and drive meaningful advancements in healthcare. We remain steadfast in delivering consistent strategic partnership and prioritizing customer success,” McGee stated.

Former CEO Dr. Mark Ostwald served Freudenberg Medical for 16 years in various leadership roles. During his tenure, the company doubled its annual revenue, expanded its global manufacturing footprint by one-third, and integrated three Joint Ventures. 

Dr. Mark Ostwald, former CEO, Freudenberg Medical, stated, “Leading this extraordinary organization was an honor and a privilege. Michael is passionately committed to our strategy and values, developing our people and delivering high-quality products to improve patients’ lives. I am convinced that Michael is the right leader to take Freudenberg Medical to the next level of success.”